Live Breaking News & Updates on Medical biochemistry diploma

Stay informed with the latest breaking news from Medical biochemistry diploma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Medical biochemistry diploma and stay connected to the pulse of your community

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Bryn Mawr Capital Management LLC

Bryn Mawr Capital Management LLC lifted its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,866 shares of the company’s stock after purchasing an additional 164 shares during the period. Bryn Mawr […]

Securities-exchange-commission , Jefferies-financial-group , Koshinski-asset-management-inc , Caprock-group , Morgan-stanley , Astrazeneca , Capital-asset-advisory-services , Deutsche-bank-aktiengesellschaft , Bryn-mawr-capital-management , Free-report , Mawr-capital-management

Bryn Mawr Capital Management LLC Acquires 6,170 Shares of Zoetis Inc. (NYSE:ZTS)

Bryn Mawr Capital Management LLC raised its holdings in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 70.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,888 shares of the company’s stock after acquiring an additional 6,170 shares during the period. Bryn […]

United-states , Zurich , Züsz , Switzerland , Roxanne-lagano , Piper-sandler , Stifel-nicolaus , Jackson-hole-capital-partners , Ltd-zurich , Barclays , Securities-exchange-commission , Sandhill-capital-partners

Stanley Laman Group Ltd. Sells 35 Shares of Stryker Co. (NYSE:SYK)

Stanley Laman Group Ltd. lessened its stake in Stryker Co. (NYSE:SYK – Free Report) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 719 shares of the medical technology company’s stock after selling 35 shares during the period. Stanley Laman Group Ltd.’s […]

Roth-mkm , Rondae-stryker , Williame-berry-jr , Stanley-laman-group-ltd , Stryker-corporation , Vanguard-group-inc , Wells-fargo-company , Charles-schwab-investment-management-inc , Canaccord-genuity-group , Exchange-commission , Northern-trust-corp , Stryker-co

Jackson Hole Capital Partners LLC Invests $211,000 in Laboratory Co. of America Holdings (NYSE:LH)

Jackson Hole Capital Partners LLC bought a new stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 930 shares of the medical research company’s stock, valued at approximately $211,000. […]

Wellington , New-zealand-general- , New-zealand , United-states , America , Marks-schroeder , Amyb-summy , Leerink-partnrs , Laboratory-co , Wellington-management-group , America-holdings , Exchange-commission

Herold Advisors Inc. Increases Position in GSK plc (NYSE:GSK)

Herold Advisors Inc. grew its position in GSK plc (NYSE:GSK – Free Report) by 5.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,681 shares of the pharmaceutical company’s stock after purchasing an additional 511 shares during the quarter. Herold Advisors Inc.’s holdings […]

United-kingdom , United-states , Aaron-wealth-advisors , Morgan-stanley , Jefferies-financial-group , Herold-advisors-inc , Citigroup , Marshall-financial-group , Kempner-capital-management-inc , Advisors-inc , Exchange-commission

Bahl & Gaynor Inc. Lowers Stake in Becton, Dickinson and Company (NYSE:BDX)

Bahl & Gaynor Inc. reduced its holdings in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 0.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 107,146 shares of the medical instruments supplier’s stock after selling 931 shares during the period. Bahl & Gaynor […]

Thomasj-spoerel , Raymond-james , Becton-dickinson , Arlington-trust-co , Bd-life-sciences , Bahl-gaynor-inc , Fortitude-family-office , Venturi-wealth-management , Company-price-performance , Company-daily , Barclays , Company-profile

Kyverna Therapeutics (NASDAQ:KYTX) Hits New 12-Month Low at $17.70

Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as $17.70 and last traded at $17.75, with a volume of 81775 shares. The stock had previously closed at $19.19. Wall Street Analysts Forecast Growth Several brokerages recently weighed in on KYTX. Morgan […]

Leerink-partnrs , Nasdaq , Kyverna-therapeutics-company-profile , Morgan-stanley , Wells-fargo-company , Northpond-ventures-iii-gp-llc , Jpmorgan-chase-co , Kyverna-therapeutics-inc , Kyverna-therapeutics , Get-free-report , Wells-fargo , Therapeutics-trading-down

Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Callan Capital LLC

Callan Capital LLC raised its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 2,506 shares of the medical research company’s stock after acquiring an additional 137 shares during the period. Callan Capital LLC’s holdings in Amgen […]

Canada , Callan-capital , Solutions-inc , Amgen , Financial-private-wealth-inc , Nasdaq , Amgen-inc , Royal-bank , Briaud-financial-planning-inc , Amgen-company-profile , Providence-capital-advisors

6,726 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Callan Capital LLC

Callan Capital LLC acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,726 shares of the company’s stock, valued at approximately $239,000. Other hedge funds have also […]

United-states , Yujiros-hata , Briseno-andres-ruiz , Leerink-partnrs , Werner-helicase , Nasdaq , Jpmorgan-chase-co , Eventide-asset-management , Barclays-plc , Biosciences-inc , Goldman-sachs-group , Walleye-capital

AbbVie (NYSE:ABBV) Issues Q2 2024 Earnings Guidance

AbbVie (NYSE:ABBV – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 3.050-3.090 for the period, compared to the consensus estimate of 2.810. The company issued revenue guidance of $14.0 billion-$14.0 billion, compared to the consensus revenue estimate of […]

William-blair , Perryc-siatis , Azita-saleki-gerhardt , Venclexta-venclyxto , Barclays , Abbvie-inc , Securities-exchange-commission , Get-free-report , Moderate-buy , Exchange-commission , Vie-inc , Abbvie-daily